Dose-response

In clinical pharmacology, the term covers the links among the dose, the concentration of a substance in the blood, and the response that follows [1]. A review of drug-development methods describes dose-response studies as useful in early trials for judging tolerance and safety, and in later trials for characterizing whether a substance works [1]. The same review lists what such studies can show: the shape and position of the dose-response curve, an appropriate starting dose, and the maximal dose beyond which more is unlikely to bring further benefit [1].

The idea applies to unwanted effects as well as wanted ones. In a review of 57 experimental and 9 survey studies of caffeine withdrawal in habitual consumers, symptoms in general became more common or more severe as the usual daily dose rose, and stopping doses as low as 100 mg a day still produced symptoms [2]. A 2026 systematic review included 48 randomized trials in 940 athletes aged 15 and over and meta-analyzed 38 of the trials; it ran dose-response analyses of acute side effects alongside its main comparison with placebo [3].

A trial that tests one amount against placebo answers a narrower question: whether that amount differed from placebo. Mapping the curve needs several doses, which is the job of dose-response studies [1].

A finding that more worked better inside the tested range also does not extend past that range, because a curve can flatten at a dose beyond which more is unlikely to help [1]. Reading a result this way keeps it tied to the amounts that were actually studied.

On NootropicsWork, doses appear only as the doses used in studies. A dose-response finding describes how a measured response changed across the amounts a study tested. It is not a recommended amount, and it says nothing about doses no study has tested.

• Half-life
• Tolerance
• Titration
• Pharmacodynamics
• Placebo